Who We Are


Michael D. Kaytor, Ph.D.

President, co-founder, and investigator

Mike is Director of Research and Development at Humanetics Corporation, a pharmaceutical company located in Minneapolis. He received his Ph.D. in Biochemistry and Molecular Biology from the University of Minnesota, and has conducted research at Emory University School of Medicine as a Post-doctoral Fellow and as an associate of the Howard Hughes Medical Institute.



Anne2Anne Kersten


 Anne is a graduate of the University of Minnesota Carlson School of Management. She has over 25 years of experience as a Finance/Accounting administrator, Administrative Manager, and Financial Advisor, and is currently a Financial Associate with Thrivent Financial.




CarolCarol J. Kaemmerer, A.C.S.W.


 Currently an executive LinkedIn coach and speaker, Carol has 25 years of experience in medical marketing communications. She has considerable expertise in making complex information about healthcare and medical technology understandable to broad audiences.




EricEric N. Burright, Ph.D.

Board member, co-founder, and investigator

Eric earned a Ph.D. in Human Genetics from the University of Michigan, and proceeded to develop one of the first transgenic mouse models of spinocerebellar ataxia as a Postdoctoral Fellow at the University of Minnesota. He has over 15 years of experience as a Staff Scientist and Senior Research Manager at various companies, and is currently Manager of Preclinical Sciences at a major corporation in the Minneapolis area.




Bill2Bill Kaemmerer, Ph.D.

Board member, co-founder, and investigator

Bill is a neuroscientist (Ph.D., University of Minnesota, 2001) and psychologist (Ph.D., Ohio State University, 1979) with 30 years of industry experience in R&D. He has been conducting laboratory and preclinical research towards the development of gene therapies for neurological diseases since he learned about the discovery of the gene mutation that causes Huntington’s disease in 1993.




JackJohn G. (Jack) Keimel

Board member, co-founder, and investigator

Jack has more than 30 years of experience as a director and executive in research and development at a major medical device company. He is now the President of the New Hope Research Foundation, a non-profit organization established in 2006 to support the scientific research and clinical studies needed to help patients neurologically impacted by lysosomal storage diseases.




 All of us are volunteers devoting our time and efforts to the CGTA Research Group because of our belief in its stated mission. We are not receiving any income or other financial compensation from the CGTA Research Group beyond reimbursement for minor incidental expenses.